Cargando…

Overexpression of TMEFF1 in Endometrial Carcinoma and the Mechanism Underlying its Promotion of Malignant Behavior in Cancer Cells

Background: Although tomoregulin-1 (TMEFF1) is involved in embryonic development and central nervous system regulation and is a cancer suppressor gene in brain cancers, its role in endometrial carcinoma remains unclear. Methods: The expression and prognostic value of TMEFF1 were analyzed by bioinfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nie, Xin, Gao, Lingling, Zheng, Mingjun, Wang, Caixia, Wang, Shuang, Li, Xiao, Qi, Yue, Zhu, Liancheng, Liu, Juanjuan, Lin, Bei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408118/ https://www.ncbi.nlm.nih.gov/pubmed/34475991 http://dx.doi.org/10.7150/jca.58524

Ejemplares similares

TMEFF1 overexpression and its mechanism for tumor promotion in ovarian cancer
por: Nie, Xin, et al.
Publicado: (2019)

Whole Genome Analysis and Prognostic Model Construction Based on Alternative Splicing Events in Endometrial Cancer
por: Wang, Caixia, et al.
Publicado: (2019)

TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
por: Xie, Sidi, et al.
Publicado: (2021)

Estrogen/estrogen receptor promotes the proliferation of endometrial carcinoma cells by enhancing hMOF expression
por: Qi, Yue, et al.
Publicado: (2020)

CircTmeff1 Promotes Muscle Atrophy by Interacting with TDP‐43 and Encoding A Novel TMEFF1‐339aa Protein
por: Chen, Rui, et al.
Publicado: (2023)

SERPIND1 Affects the Malignant Biological Behavior of Epithelial Ovarian Cancer via the PI3K/AKT Pathway: A Mechanistic Study
por: Guo, Qian, et al.
Publicado: (2019)

Overexpression of BMPER in Ovarian Cancer and the Mechanism by which It Promotes Malignant Biological Behavior in Tumor Cells
por: Xi, Yong, et al.
Publicado: (2020)

Butorphanol Inhibits the Malignant Biological Behaviors of Ovarian Cancer Cells via Down-Regulating the Expression of TMEFF1
por: Wang, Baosheng, et al.
Publicado: (2020)

Expression of TMEFF2 in Human Pancreatic Cancer Tissue and the Effects of TMEFF2 Knockdown on Cell, Proliferation, and Apoptosis in Human Pancreatic Cell Lines
por: Li, Kailiang, et al.
Publicado: (2019)

Combining Bioinformatics and Experiments to Identify and Verify Key Genes with Prognostic Values in Endometrial Carcinoma
por: Zhang, Wenchao, et al.
Publicado: (2020)

Low BCL9 expression inhibited ovarian epithelial malignant tumor progression by decreasing proliferation, migration, and increasing apoptosis to cancer cells
por: Wang, Jing, et al.
Publicado: (2019)

Tmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivo
por: Huang, Hao, et al.
Publicado: (2017)

The Role of circTmeff-1 in Morphine Addiction Memory of Mice
por: Yu, Hailei, et al.
Publicado: (2023)

TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease
por: Masood, Motasim, et al.
Publicado: (2020)

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
por: Gou, Rui, et al.
Publicado: (2022)

ZNF703 promotes tumor progression in ovarian cancer by interacting with HE4 and epigenetically regulating PEA15
por: Wang, Shuang, et al.
Publicado: (2020)

Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
por: Wang, Shuang, et al.
Publicado: (2020)

MIR503HG impeded ovarian cancer progression by interacting with SPI1 and preventing TMEFF1 transcription
por: Tian, Jun, et al.
Publicado: (2022)

Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer
por: Gao, Lingling, et al.
Publicado: (2021)

Expression of HE4 in Endometrial Cancer and Its Clinical Significance
por: Li, Xiao, et al.
Publicado: (2015)

Androgen Signaling Promotes Translation of TMEFF2 in Prostate Cancer Cells via Phosphorylation of the α Subunit of the Translation Initiation Factor 2
por: Overcash, Ryan F., et al.
Publicado: (2013)

Corrigendum to “Expression of HE4 in Endometrial Cancer and Its Clinical Significance”
por: Li, Xiao, et al.
Publicado: (2018)

YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways
por: Li, Xiao, et al.
Publicado: (2021)

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer
por: Gaweł‐Bęben, Katarzyna, et al.
Publicado: (2017)

A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer
por: Georgescu, Constantin, et al.
Publicado: (2019)

TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway
por: Han, Hongchao, et al.
Publicado: (2019)

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysis
por: Gao, Lingling, et al.
Publicado: (2020)

Interaction of HE4 and ANXA2 exists in various malignant cells—HE4–ANXA2–MMP2 protein complex promotes cell migration
por: Wang, Jing, et al.
Publicado: (2019)

Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
por: Wang, Chun-Fang, et al.
Publicado: (2013)

Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma
por: Shen, Qi, et al.
Publicado: (2020)

HERPUD1 promotes ovarian cancer cell survival by sustaining autophagy and inhibit apoptosis via PI3K/AKT/mTOR and p38 MAPK signaling pathways
por: Nie, Xin, et al.
Publicado: (2022)

GNA14 stimulation of KLF7 promotes malignant growth of endometrial cancer through upregulation of HAS2
por: Wang, Jing, et al.
Publicado: (2021)

TMEFF2 Is a PDGF-AA Binding Protein with Methylation-Associated Gene Silencing in Multiple Cancer Types Including Glioma
por: Lin, Kui, et al.
Publicado: (2011)

CRKL overexpression promotes cell proliferation and inhibits apoptosis in endometrial carcinoma
por: Cai, Le, et al.
Publicado: (2017)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

Roles of miR-592-3p and Its Target Gene, TMEFF1, in the Nucleus Accumbens During Incubation of Morphine Craving
por: Xie, Bing, et al.
Publicado: (2022)

Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
por: Gao, Lingling, et al.
Publicado: (2020)

Decreased PTGDS Expression Predicting Poor Survival of Endometrial Cancer by Integrating Weighted Gene Co-Expression Network Analysis and Immunohistochemical Validation
por: Zou, Ruoyao, et al.
Publicado: (2020)

Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer
por: Zhu, Liancheng, et al.
Publicado: (2015)

Lewis y antigen promotes the proliferation of ovarian carcinoma-derived RMG-I cells through the PI3K/Akt signaling pathway
por: Liu, Juanjuan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q1f7d0812isa3jnb3i82eui987